Safety and activity of IT-139, a ruthenium-based compound, in patients with advanced solid tumours: a first-in-human, open-label, dose-escalation phase I study with expansion cohort. (Q55065627)
Jump to navigation
Jump to search
scientific article published in January 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and activity of IT-139, a ruthenium-based compound, in patients with advanced solid tumours: a first-in-human, open-label, dose-escalation phase I study with expansion cohort. |
scientific article published in January 2016 |
Statements
1 reference
Safety and activity of IT-139, a ruthenium-based compound, in patients with advanced solid tumours: a first-in-human, open-label, dose-escalation phase I study with expansion cohort. (English)
1 reference
Howard A Burris
1 reference
Suzanne Bakewell
1 reference
Johanna C Bendell
1 reference
Jeffrey Infante
1 reference
Suzanne F Jones
1 reference
David R Spigel
1 reference
Glen J Weiss
1 reference
Ramesh K Ramanathan
1 reference
Angela Ogden
1 reference
Daniel Von Hoff
1 reference
1 January 2016
1 reference
1 reference
1
1 reference
6
1 reference
e000154
1 reference
1 reference
Identifiers
1 reference
1 reference